PT1427436E - Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral - Google Patents
Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral Download PDFInfo
- Publication number
- PT1427436E PT1427436E PT02796345T PT02796345T PT1427436E PT 1427436 E PT1427436 E PT 1427436E PT 02796345 T PT02796345 T PT 02796345T PT 02796345 T PT02796345 T PT 02796345T PT 1427436 E PT1427436 E PT 1427436E
- Authority
- PT
- Portugal
- Prior art keywords
- mixture
- viral infection
- microbial
- prophylaxis
- treatment
- Prior art date
Links
- 102000006410 Apoproteins Human genes 0.000 title abstract 3
- 108010083590 Apoproteins Proteins 0.000 title abstract 3
- 235000013336 milk Nutrition 0.000 title abstract 3
- 239000008267 milk Substances 0.000 title abstract 3
- 210000004080 milk Anatomy 0.000 title abstract 3
- 208000036142 Viral infection Diseases 0.000 title abstract 2
- 230000000813 microbial effect Effects 0.000 title abstract 2
- 230000009385 viral infection Effects 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title 1
- 210000002966 serum Anatomy 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 5
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- 229940012356 eye drops Drugs 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000007922 nasal spray Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000003182 parenteral nutrition solution Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Marine Sciences & Fisheries (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IES20010780 | 2001-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1427436E true PT1427436E (pt) | 2008-09-08 |
Family
ID=11042830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02796345T PT1427436E (pt) | 2001-08-23 | 2002-08-20 | Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7687074B2 (https=) |
| EP (1) | EP1427436B1 (https=) |
| JP (1) | JP4532900B2 (https=) |
| KR (1) | KR100907959B1 (https=) |
| CN (1) | CN1578670B (https=) |
| AT (1) | ATE399562T1 (https=) |
| AU (1) | AU2002356112B2 (https=) |
| CA (1) | CA2458146C (https=) |
| DE (1) | DE60227389D1 (https=) |
| DK (1) | DK1427436T3 (https=) |
| ES (1) | ES2309228T3 (https=) |
| NZ (1) | NZ531639A (https=) |
| PT (1) | PT1427436E (https=) |
| RU (1) | RU2305547C2 (https=) |
| WO (1) | WO2003018049A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2863168A1 (fr) * | 2003-12-04 | 2005-06-10 | Centre Nat Rech Scient | Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone. |
| BRPI0512864B8 (pt) * | 2004-07-01 | 2021-05-25 | Johnson & Johnson Vision Care | composição oftálmica, uso de pelo menos um ácido graxo ômega-6 e pelo menos um ácido graxo ômega-3 e método para preparar a referida composição |
| WO2007035870A2 (en) * | 2005-09-20 | 2007-03-29 | Prolacta Bioscience, Inc. | A method for testing milk |
| WO2007061942A2 (en) | 2005-11-18 | 2007-05-31 | Glanbia Nutritionals (Ireland) Ltd. | Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| JP5017531B2 (ja) * | 2006-09-11 | 2012-09-05 | 株式会社アップウェル | 口内清浄剤 |
| KR20100108526A (ko) * | 2007-12-04 | 2010-10-07 | 웨스트게이트 바이올로지컬 리미티드 | 지방산 및 우유 단백질을 포함하는 항균성 조성물 |
| JP2009190994A (ja) * | 2008-02-13 | 2009-08-27 | Kitasato Institute | 抗インフルエンザウイルス剤、及びその有効成分の製造方法 |
| US20090311236A1 (en) * | 2008-06-11 | 2009-12-17 | Immune @Work, Inc. | Therapeutic Peptide Compositions And Methods Of Making And Using Same |
| EP2316445A4 (en) * | 2008-06-11 | 2011-12-21 | Ricom Corp | HUMAN BETA3 ADRENERGER RECEPTOR LIGAND AND THEREOF FOOD OR PHARMACEUTICAL PREPARATION |
| US8808345B2 (en) * | 2008-12-31 | 2014-08-19 | Medtronic Ardian Luxembourg S.A.R.L. | Handle assemblies for intravascular treatment devices and associated systems and methods |
| WO2010082587A1 (ja) * | 2009-01-13 | 2010-07-22 | 株式会社大気倶楽部 | 空中懸濁物吸着剤 |
| KR101119538B1 (ko) * | 2009-06-10 | 2012-02-22 | 장선호 | 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방 및 치료용 조성물 |
| ES2643862T3 (es) * | 2009-11-17 | 2017-11-24 | Michael Anthony Folan | Composiciones antimicrobianas que contienen ácidos grasos libres |
| AR082943A1 (es) * | 2010-08-06 | 2013-01-23 | Aptalis Pharma Ltd | Formula nutricional predigerida |
| KR101355018B1 (ko) * | 2010-12-13 | 2014-01-24 | 노부오 구보 | 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방용 동물사료 첨가제 및 이를 포함하는 동물사료용 조성물 |
| RU2494726C2 (ru) * | 2011-04-11 | 2013-10-10 | Общество с Ограниченной Ответственностью "Производственная Торговая Компания "Лактив" | Способ профилактики и лечения грибковой инфекции у больных с голосовыми протезами |
| EP3150257A1 (en) * | 2015-09-30 | 2017-04-05 | Buga, Doris | A method for producing a composition for strengthening the immune system |
| CA3026402A1 (en) | 2017-12-05 | 2019-06-05 | James F. Kane | Water-soluble cannabinoids and methods of making same |
| US11298379B2 (en) * | 2020-04-16 | 2022-04-12 | James F. Kane | Compositions comprising milk fat globules and methods of making same |
| CN113855787A (zh) * | 2020-06-30 | 2021-12-31 | 北京大学 | 乳清蛋白作为冠状病毒广谱抑制剂的用途 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2796378A (en) * | 1954-04-09 | 1957-06-18 | Jr Edgar A Ferguson | Methionine free reaction product of a water-soluble copper salt and lactalbumin hydrolysate as fungicide |
| GB1050756A (https=) * | 1964-09-10 | 1900-01-01 | ||
| US4397927A (en) * | 1982-03-25 | 1983-08-09 | Brog Roy A | Imitation milk compositions and aqueous dispersions prepared therefrom |
| EP0210204B1 (de) | 1985-01-18 | 1988-12-07 | Kailash Kumar Dr. Prof. Gauri | Proteinhydrolysate, verfahren zu ihrer herstellung und arzneimittel, die diese hydrolysate enthalten |
| JPS62249931A (ja) | 1986-04-21 | 1987-10-30 | Morinaga Milk Ind Co Ltd | 抗菌性組成物 |
| JPH085798B2 (ja) * | 1987-02-02 | 1996-01-24 | 紀夫 多田 | 抗菌剤 |
| DE69003014T2 (de) * | 1989-06-07 | 1993-12-16 | Kao Corp | Essbare Öl-in-Wasser-Emulsion. |
| JP2673320B2 (ja) * | 1990-01-25 | 1997-11-05 | 雪印乳業株式会社 | う蝕原菌付着阻止剤 |
| JPH04159232A (ja) * | 1990-08-21 | 1992-06-02 | Yakult Honsha Co Ltd | 日和見感染症予防・治療用経口組成物 |
| CA2094570A1 (en) | 1992-05-27 | 1993-11-28 | Jerome F. Trumbetas | Enzymatic protein process and product |
| CA2148261A1 (en) | 1992-10-30 | 1994-05-11 | Jerry A. Peterson | Anti-diarrheic product and method of treating rotavirus-associated infection |
| US5785984A (en) * | 1993-02-05 | 1998-07-28 | Kao Corporation | Taste-modifying method and bitterness-decreasing method |
| US6197356B1 (en) * | 1993-08-03 | 2001-03-06 | Immunopath Profile, Inc. | Process for preparing hypoallergenic foods |
| AU7792294A (en) * | 1994-08-16 | 1996-03-07 | Hemant Sabharwal | Antibacterial composition containing multimeric alpha-lactalbumin |
| JP4233615B2 (ja) * | 1996-08-22 | 2009-03-04 | 森永乳業株式会社 | 経口抗ヒト爪白癬及び／又は爪白癬以外のヒト足部白癬用医薬品 |
| DE69824150T2 (de) | 1997-01-09 | 2005-05-25 | Morinaga Milk Industry Co. Ltd. | Lactoferrin-tabletten |
| IE970541A1 (en) | 1997-07-25 | 1999-01-27 | Michael Anthony Folan | Maternal immune secretions and their use in the treatment and/or prophylaxis of the buccal cavity |
| JP4129566B2 (ja) * | 1997-09-05 | 2008-08-06 | 大塚製薬株式会社 | 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤 |
| US6287590B1 (en) | 1997-10-02 | 2001-09-11 | Esperion Therapeutics, Inc. | Peptide/lipid complex formation by co-lyophilization |
| AUPP051497A0 (en) | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
| US6126955A (en) * | 1998-04-16 | 2000-10-03 | University Of Utah Research Foundation | Apo-transferrin as a potent inhibitor of bacterial adhesion to biomaterials |
| ATE259654T1 (de) | 1998-06-26 | 2004-03-15 | Nutricia Nv | Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen |
| JP2000119257A (ja) * | 1998-08-14 | 2000-04-25 | Nippon Nohyaku Co Ltd | ピリダジノン誘導体 |
| GB9903584D0 (en) | 1999-02-18 | 1999-04-07 | Univ Leeds | Modified calycins |
| JP3662445B2 (ja) * | 1999-06-30 | 2005-06-22 | 花王株式会社 | 油中水型乳化油脂組成物 |
| WO2002094035A1 (en) * | 2001-05-23 | 2002-11-28 | Nutricopia, Inc. | Nutritional frozen dessert and methods of manufacture |
| US20030165606A1 (en) | 2001-07-18 | 2003-09-04 | Lasekan John B. | Anti-regurgitation formula and uses thereof |
| EP1319407A1 (en) * | 2001-12-14 | 2003-06-18 | Montoie Import-Export S.A. | Pharmaceutical composition for topical treatment of skin disorders and skin wounds |
-
2002
- 2002-08-20 WO PCT/IE2002/000121 patent/WO2003018049A2/en not_active Ceased
- 2002-08-20 CA CA2458146A patent/CA2458146C/en not_active Expired - Fee Related
- 2002-08-20 JP JP2003522566A patent/JP4532900B2/ja not_active Expired - Fee Related
- 2002-08-20 PT PT02796345T patent/PT1427436E/pt unknown
- 2002-08-20 CN CN028210786A patent/CN1578670B/zh not_active Expired - Fee Related
- 2002-08-20 DE DE60227389T patent/DE60227389D1/de not_active Expired - Lifetime
- 2002-08-20 AU AU2002356112A patent/AU2002356112B2/en not_active Ceased
- 2002-08-20 ES ES02796345T patent/ES2309228T3/es not_active Expired - Lifetime
- 2002-08-20 KR KR1020047002518A patent/KR100907959B1/ko not_active Expired - Fee Related
- 2002-08-20 US US10/487,616 patent/US7687074B2/en not_active Expired - Lifetime
- 2002-08-20 DK DK02796345T patent/DK1427436T3/da active
- 2002-08-20 NZ NZ531639A patent/NZ531639A/en not_active IP Right Cessation
- 2002-08-20 RU RU2004108040/13A patent/RU2305547C2/ru not_active IP Right Cessation
- 2002-08-20 AT AT02796345T patent/ATE399562T1/de active
- 2002-08-20 EP EP02796345A patent/EP1427436B1/en not_active Expired - Lifetime
-
2010
- 2010-01-30 US US12/657,884 patent/US7972629B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040041579A (ko) | 2004-05-17 |
| DE60227389D1 (de) | 2008-08-14 |
| WO2003018049A2 (en) | 2003-03-06 |
| CN1578670B (zh) | 2013-09-04 |
| JP2005501863A (ja) | 2005-01-20 |
| CA2458146A1 (en) | 2003-03-06 |
| NZ531639A (en) | 2006-02-24 |
| EP1427436A2 (en) | 2004-06-16 |
| ES2309228T3 (es) | 2008-12-16 |
| KR100907959B1 (ko) | 2009-07-16 |
| EP1427436B1 (en) | 2008-07-02 |
| US7687074B2 (en) | 2010-03-30 |
| CA2458146C (en) | 2012-07-24 |
| US7972629B2 (en) | 2011-07-05 |
| RU2305547C2 (ru) | 2007-09-10 |
| AU2002356112B2 (en) | 2007-11-08 |
| US20050042299A1 (en) | 2005-02-24 |
| RU2004108040A (ru) | 2005-09-27 |
| CN1578670A (zh) | 2005-02-09 |
| WO2003018049A3 (en) | 2003-11-06 |
| JP4532900B2 (ja) | 2010-08-25 |
| US20100209526A1 (en) | 2010-08-19 |
| DK1427436T3 (da) | 2008-10-13 |
| ATE399562T1 (de) | 2008-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1427436E (pt) | Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral | |
| KR101501790B1 (ko) | 감염성 피부 및 점막 질환 치료약 | |
| US20100144618A1 (en) | Compositions containing an intestinal trefoil peptide and a mucoadhesive | |
| IL139231A0 (en) | Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract | |
| Almeida et al. | Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials | |
| US7538082B2 (en) | Methods and compositions for treating oral and esophageal lesions | |
| MXPA03000353A (es) | Medicamentos para tratamiento quimioterapeutico de enfermedades. | |
| GB9510037D0 (en) | Improvements in or relating to organic compounds | |
| MY159377A (en) | Aqueous suspensions of ciclesonide for nebulisation | |
| CA2387095A1 (en) | Compound with growth hormone releasing properties | |
| HUP0401672A2 (hu) | Kis koncentrációjú peroxid alkalmazása hüvelyi fertőzések gyógyító vagy megelőző kezelésénél | |
| DE60031016D1 (de) | Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen | |
| WO2000016786A3 (en) | Oxihumic acid and its use in the treatment of various conditions | |
| WO2014205159A1 (en) | Poloxamer based inhalation composition | |
| DE60043886D1 (de) | Formulierungen mit povidon-iod zur behandlung von wunden | |
| Ampel | Lopinavir-ritonavir was not effective for COVID-19 | |
| WO2007139433A8 (en) | Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application | |
| Hamad | Minocycline superior to chloroquine phosphate as COVID-19 treatment | |
| RU2418597C1 (ru) | Способ лечения хронического тонзиллита | |
| JP2004529095A (ja) | 抗菌性ｉｂ−３６７ペプチドの経口投与による人工呼吸器関連性肺炎の予防法 | |
| NZ587372A (en) | Treatment of bacterial, protozoan infections and cancer with a mixture of at least three different human interferon alpha proteins | |
| RU1782597C (ru) | Способ профилактики некроза кожного лоскута на питательной ножке | |
| AU2003294834A1 (en) | Anthranilic acid amide derivatives and their pharmaceutical use | |
| RU2180532C2 (ru) | Способ лечения папилломатоза | |
| AP1629A (en) | Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes. |